Since aberrant activation of NF-κB has been observed in a wide range of human cancers and is thought to promote tumorigenesis and metastasis, we speculate E.d’s chronic proliferation in the inflamed gut will promote tumorigenesis through aberrant activation of NF-κB. This evidence concerns the gene NFKB1 and cancer.